These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7800164)

  • 1. Psychoimmune investigation in obsessive-compulsive disorder: assays of plasma transferrin, IL-2 and IL-6 receptor, and IL-1 beta and IL-6 concentrations.
    Maes M; Meltzer HY; Bosmans E
    Neuropsychobiology; 1994; 30(2-3):57-60. PubMed ID: 7800164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression.
    Maes M; Meltzer HY; Bosmans E; Bergmans R; Vandoolaeghe E; Ranjan R; Desnyder R
    J Affect Disord; 1995 Aug; 34(4):301-9. PubMed ID: 8550956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression.
    Maes M; Meltzer HY; Buckley P; Bosmans E
    Eur Arch Psychiatry Clin Neurosci; 1995; 244(6):325-9. PubMed ID: 7772617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased blood levels of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder.
    Monteleone P; Catapano F; Fabrazzo M; Tortorella A; Maj M
    Neuropsychobiology; 1998; 37(4):182-5. PubMed ID: 9648125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers.
    Maes M; Bosmans E; Calabrese J; Smith R; Meltzer HY
    J Psychiatr Res; 1995; 29(2):141-52. PubMed ID: 7666381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine.
    Maes M; Meltzer HY; Bosmans E
    Acta Psychiatr Scand; 1994 May; 89(5):346-51. PubMed ID: 8067274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of anticoagulation and processing on assays of IL-6, sIL-6R, sIL-2R and soluble transferrin receptor.
    De Jongh R; Vranken J; Vundelinckx G; Bosmans E; Maes M; Heylen R
    Cytokine; 1997 Sep; 9(9):696-701. PubMed ID: 9325019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seasonal variation in peripheral blood leukocyte subsets and in serum interleukin-6, and soluble interleukin-2 and -6 receptor concentrations in normal volunteers.
    Maes M; Stevens W; Scharpé S; Bosmans E; De Meyer F; D'Hondt P; Peeters D; Thompson P; Cosyns P; De Clerck L
    Experientia; 1994 Sep; 50(9):821-9. PubMed ID: 7523180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders.
    Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble interleukin-6 receptor as a prognostic factor in multiple myeloma. Finnish Leukaemia Group.
    Pulkki K; Pelliniemi TT; Rajamäki A; Tienhaara A; Laakso M; Lahtinen R
    Br J Haematol; 1996 Feb; 92(2):370-4. PubMed ID: 8603002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disgust affects TNF-alpha, IL-6 and noradrenalin levels in patients with obsessive-compulsive disorder.
    Fluitman SB; Denys DA; Heijnen CJ; Westenberg HG
    Psychoneuroendocrinology; 2010 Jul; 35(6):906-11. PubMed ID: 20044210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6, soluble interleukin-2 receptor and soluble interleukin-6 receptor in the sera of patients with different histological patterns of rheumatoid synovitis.
    Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik JP; Cylwik B; Skowronski J; Chwiecko J
    Clin Exp Rheumatol; 2003; 21(1):63-9. PubMed ID: 12673891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid interleukin-6 in obsessive-compulsive disorder and trichotillomania.
    Carpenter LL; Heninger GR; McDougle CJ; Tyrka AR; Epperson CN; Price LH
    Psychiatry Res; 2002 Nov; 112(3):257-62. PubMed ID: 12450635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased TNF-alpha and NK activity in obsessive-compulsive disorder.
    Denys D; Fluitman S; Kavelaars A; Heijnen C; Westenberg H
    Psychoneuroendocrinology; 2004 Aug; 29(7):945-52. PubMed ID: 15177711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment.
    Erbağci AB; Herken H; Köylüoglu O; Yilmaz N; Tarakçioglu M
    Mediators Inflamm; 2001 Jun; 10(3):109-15. PubMed ID: 11545247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease.
    Salvi M; Girasole G; Pedrazzoni M; Passeri M; Giuliani N; Minelli R; Braverman LE; Roti E
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2976-9. PubMed ID: 8768861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 beta differentially affects interleukin-6 and soluble interleukin-6 receptor in the blood and central nervous system of the monkey.
    Reyes TM; Coe CL
    J Neuroimmunol; 1996 May; 66(1-2):135-41. PubMed ID: 8964907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of serum interleukin-1 beta in combat-related posttraumatic stress disorder.
    Spivak B; Shohat B; Mester R; Avraham S; Gil-Ad I; Bleich A; Valevski A; Weizman A
    Biol Psychiatry; 1997 Sep; 42(5):345-8. PubMed ID: 9276074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-inflammatory markers in patients with seasonal affective disorder: effects of light therapy.
    Leu SJ; Shiah IS; Yatham LN; Cheu YM; Lam RW
    J Affect Disord; 2001 Mar; 63(1-3):27-34. PubMed ID: 11246077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo immunomodulatory effects of clozapine in schizophrenia.
    Maes M; Bosmans E; Kenis G; De Jong R; Smith RS; Meltzer HY
    Schizophr Res; 1997 Aug; 26(2-3):221-5. PubMed ID: 9323354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.